A treat-to-target strategy, in which treatment is continuously adjusted according to the results of scheduled objective monitoring, is optimal for patients with Crohn’s disease (CD) in the era of biologics. The small bowel is a common site of intractable CD, which may result from multiple strictures or expanding lesions. To improve the prognosis of patients with small bowel CD, lesions should be proactively monitored within the subclinical phase. Objective assessment of small bowel lesions is technically difficult, however, due to the relatively poor correlation between endoscopic activity and clinical symptoms or biomarker titers. The presence of proximal small bowel lesions and asymptomatic “Real Silent CD” must be considered. Endoscopy remains the gold standard to assess these lesions. In clinical practice, the advantages and disadvantages of each imaging modality and biomarker must be carefully weighed for appropriate application and reliable monitoring. The prevalence of small bowel lesions depends on the precision of the imaging modality used for detection. Clinical management should be based on the dominant location of the intestinal lesions rather than classical classification. Optimal strategies for detecting and treating small bowel lesions in patients with CD must be developed utilizing reliable, precise, and objective monitoring.
Citations
Citations to this article as recorded by
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease Sunil Samnani, Emily C L Wong, Hasan Hamam, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula Journal of Crohn's and Colitis.2025;[Epub] CrossRef
Intestinal ultrasound accurately predicts future therapy failure in Crohn’s disease patients in a biologics-induced remission Ahmad Albshesh, Alon Abend, Reuma Margalit Yehuda, Hussein Mahajna, Bella Ungar, Shomron Ben-Horin, Uri Kopylov, Dan Carter European Journal of Gastroenterology & Hepatology.2025; 37(2): 184. CrossRef
Small bowel vasculitis? what a gastroenterologist should know - from diagnosis to management João Carlos Gonçalves, Bruno Rosa, José Cotter Current Opinion in Gastroenterology.2025; 41(3): 132. CrossRef
Leucine-rich alpha-2 glycoprotein as a superior biomarker to C-reactive protein for detecting small bowel lesions in Crohn’s disease Masashi Ohno, Atsushi Nishida, Akinori Otsuki, Yoshihiro Yokota, Takayuki Imai, Shigeki Bamba, Osamu Inatomi World Journal of Gastrointestinal Endoscopy.2025;[Epub] CrossRef
Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases Takayuki Matsumoto, Tadakazu Hisamatsu, Motohiro Esaki, Teppei Omori, Hirotake Sakuraba, Shinichiro Shinzaki, Ken Sugimoto, Kento Takenaka, Makoto Naganuma, Shigeki Bamba, Takashi Hisabe, Sakiko Hiraoka, Mikihiro Fujiya, Minoru Matsuura, Shunichi Yanai, K Digestive Endoscopy.2025; 37(4): 319. CrossRef
Role of noncontrast enhanced abdominal ultrasound in the diagnostic assessment of pediatric inflammatory bowel disease Katie Ritchie, Angharad Vernon‐Roberts, Andrew S. Day Journal of Pediatric Gastroenterology and Nutrition.2025; 80(6): 979. CrossRef
Comparison of an Endoscopic Scoring System and the Simplified Magnetic Resonance Index of Activity in Patients with Small Bowel Crohn’s Disease Ji Eun Na, Hon Soul Kim, Sung Noh Hong, Kyoung Doo Song, Ji Eun Kim, Eun Ran Kim, Young-Ho Kim, Dong Kyung Chang Gut and Liver.2024; 18(1): 97. CrossRef
Use of double-balloon endoscopy and an endoscopic scoring system to assess endoscopic remission in isolated small bowel Crohn’s disease after treatment with infliximab Wei Han, Jing Hu, Juan Wu, Peipei Zhang, Qiuyuan Liu, Naizhong Hu, Qiao Mei Therapeutic Advances in Gastroenterology.2024;[Epub] CrossRef
Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi Intestinal Research.2023; 21(1): 148. CrossRef
Impact of Crohn’s Disease on the Survival of Patients with Small-Bowel Adenocarcinoma in Korea: A Bicenter Cohort Study Kyuwon Kim, Kookhwan Choi, Sung Wook Hwang, Jong Pil Im, Byong Duk Ye, Joo Sung Kim, Kyu Joo Park, Suk-Kyun Yang, Seong-Joon Koh, Sang Hyoung Park Gut and Liver.2023; 17(4): 581. CrossRef
Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome Da-Yeon Kang, Jong-Lyul Park, Min-Kyung Yeo, Sang-Bum Kang, Jin-Man Kim, Ju Seok Kim, Seon-Young Kim BMC Microbiology.2023;[Epub] CrossRef
Combined Endoscopic and Radiologic Healing Is Associated With a Better Prognosis Than Endoscopic Healing Only in Patients With Crohn's Disease Receiving Anti-TNF Therapy Kyunghwan Oh, Eun Hye Oh, Soo Min Noh, Seong Ho Park, Nayoung Kim, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye Clinical and Translational Gastroenterology.2022; 13(1): e00442. CrossRef
Clinical factors to predict flare-up in patients with inflammatory bowel disease during international air travel: A prospective study Jihye Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Alaa El-Hussuna PLOS ONE.2022; 17(1): e0262571. CrossRef
Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee, Sung Kyoung Moon Gut and Liver.2022; 16(2): 157. CrossRef
Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment Hye Kyung Hyun, Hyun-Soo Zhang, Jongwook Yu, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon BMC Gastroenterology.2022;[Epub] CrossRef
Is radiological healing alone enough? ‘Can’t take my eyes off’ the mucosa Su Hyun Park, Sang Hyoung Park The Korean Journal of Internal Medicine.2022; 37(3): 551. CrossRef
Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study Sun-Ho Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Byong Duk Ye Intestinal Research.2022; 20(2): 203. CrossRef
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence Jongwook Yu, Hye Kyung Hyun, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon Gut and Liver.2022; 16(3): 414. CrossRef
Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests José María Paredes, Tomás Ripollés, Ángela Algarra, Rafael Diaz, Nadia Moreno, Patricia Latorre, María Jesús Martínez, Pilar Llopis, Antonio López, Eduardo Moreno-Osset Intestinal Research.2022; 20(3): 361. CrossRef
Radiation Exposure among Patients with Inflammatory Bowel Disease: A Single-Medical-Center Retrospective Analysis in Taiwan Chen-Ta Yang, Hsu-Heng Yen, Yang-Yuan Chen, Pei-Yuan Su, Siou-Ping Huang Journal of Clinical Medicine.2022; 11(17): 5050. CrossRef
Capsule endoscopy in Crohn's disease surveillance: A monocentric, retrospective analysis in Italy Carlo Calabrese, Dania Gelli, Fernando Rizzello, Paolo Gionchetti, Rafael Torrejon Torres, Rhodri Saunders, Jason Davis Frontiers in Medical Technology.2022;[Epub] CrossRef
Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease Jiyoung Yoon, Dae Sung Kim, Ye-Jee Kim, Jin Wook Lee, Seung Wook Hong, Ha Won Hwang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang World Journal of Gastroenterology.2021; 27(19): 2353. CrossRef
Is Paradigm for the Role of Balloon-Assisted Enteroscopy Changing in Crohn’s Disease? Yoo Jin Lee Gut and Liver.2021; 15(3): 325. CrossRef
Epithelial Regeneration Ability of Crohn’s Disease Assessed Using Patient-Derived Intestinal Organoids Chansu Lee, Sung-Noh Hong, Eun-Ran Kim, Dong-Kyung Chang, Young-Ho Kim International Journal of Molecular Sciences.2021; 22(11): 6013. CrossRef
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease Shana Rakowsky, Adam S. Cheifetz, Konstantinos Papamichael Alimentary Pharmacology & Therapeutics.2021; 54(8): 1085. CrossRef
Another Piece of Evidence for Early Administration of Biologics in Children with Crohn's Disease Who Start as an Inflammatory Phenotype Hyuk Yoon Gut and Liver.2021; 15(6): 791. CrossRef
Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom? Soo-Young Na, Yun-Jeong Lim Diagnostics.2021; 11(12): 2240. CrossRef